Flomark is on a mission to transform the way fluid balance is monitored in healthcare settings. The company’s innovative technology addresses critical gaps in patient care by providing accurate data on infusion flow rates and urine output.
Flomark has raised €351k across 1 funding round from 2 investors, most recently a round in Jun 2025. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-06-12 | Other | €351k |
| British Design Fund (BDF),Imperial College Enterprise Fund (ICEF) |
| View deal → |
